分享至
简介
基本信息
技术文档
上下游信息
相关文章
评价
咨询
售后
产品简介
Information NVP-BSK805 2HCl is a potent and selective ATP-competitiveJAK2inhibitor withIC50of 0.5 nM,>20-fold selectivity towards JAK1, JAK3 and TYK2. Targets JAK2 (Cell-free assay); TYK2 (Cell-free assay); JAK3 (Cell-free assay); JAK1 (Cell-free assay) ~0.5 nM; 10.76 nM; 18.68 nM; 31.63 nM In vitro NVP-BSK805 is found to potently inhibit JAK2, whereas displaying more than 20-fold selectivity towards JAK1, JAK3, and TYK2. NVP-BSK805 causes half-maximal inhibition of full-length JAK2 V617F and JAK2 wild-type enzymes at 0.5 nM. NVP-BSK805 blocks the growth of JAK2 V617F cells (Ba/F3) and induces apoptosis with a GI50 at concentrations <100 nM. As constitutive STAT5 phosphorylation in dependent on JAK2, NVP-BSK805 is found to potently suppress STAT5 phophorylation at ≥ 100 nM concentrations in the JAK2 V617F -mutant cell lines, like MB-02. Incubation of SET-2 cells with 150 nM and 1µM of NVP-BSK805, which corresponds to concentration yielding 75% and 95% growth inhibition, respectively, for 24, 48, and 72 hours lead to concentration- and time- dependent induction of apoptosis. These results are evidenced by the detection of cleaved PARP, reduced Bcl-xL expression, and a strong increase in the number of cells with less than 2N DNA content. NVP-BSK805 triggered cell death requires activation of caspase cascades and is overcome by caspase inhibition in both SET-2 and MB-02 cells. NVP-BSK805 modulates the post-translational modification of Bim and levels of Mcl-1 in JAK2 V617F cells, SET-2 and MB-02 cells. In vivo Oral bioavailability of NVP-BSK805 in mice is estimated to be 45%, while it is 50% in rats. Oral administration of NVP-BSK805 at 150 mg/kg suppresses STAT5 phosphorylation, splenomegaly, and leukemic cell spreading in a Ba/F3 JAK2 V617F cell–driven mouse model. NVP-BSK805 suppresses rhEpo-induced STAT5 phosphorylation as well as rhEpo-mediated polycythemia and splenomegaly in BALB/c mice at doses of 25, 50, and 100 mg/kg orally. Cell Research(from reference) Cell lines:Ba/F3 cells Concentrations:100 nM Incubation Time:72 hours
中文名称
NVP-BSK805 2HCl
英文名称
NVP-BSK805 2HCl
中文别名
-
英文别名
BSK805 | BSK 805 | NVP-BSK805 2HCl | tert-butyl hydrazine carboxylate | J-002254 | SCHEMBL23860571 | BCP23423 | HY-14722A | NVP-BSK805 2HCl (1092499-93-8(free base)) | AKOS028109721 | NVP-BSK805 dihydrochloride;BSK805 dihydrochloride;NVPBSK805;NVP BSK805;
CAS号
1942919-79-0
分子式
C27H28F2N6O.2HCl
分子量
563.47 g/mol
精确质量
≥97%
PSA
68.100 Ų
Logp
3.92
技术文档
「暂无技术文档」
上下游信息
「暂无上下游信息」
相关文章
「暂无相关文章」
用户评价
加载中...
商品咨询

温馨提示:

因厂家可能临时调整产品规格、价格、库存、参数等信息且不另行通知,同时每位用户的咨询时间、采购需求存在差异,平台回复内容仅在一定时期内具有参考价值。由此给您带来的不便,敬请谅解,感谢您的理解与支持!最新详细信息请咨询在线客服,一切以客服实时回复为准!

售后服务

收到货品请及时核对数量、外观及产品信息,如遇破损、错发、质量异常等问题,欢迎随时联系我们。

服务热线:400-6226-992 ,我们将第一时间为您处理,感谢您的支持与信任!

NVP-BSK805 2HCl 100mg

JAK3 选择性抑制剂

品牌:阿拉丁
货号:N412792-100mg
级别: ≥97%
货期:30天
已售 945 件
2996
.28
3595
.54
配送至: 请选择地址
运费:0 元
规格:

100mg

数量

精选好物